Advertisement
EVCM vs HCAT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVCM is a Hold and HCAT is a Hold.
EVCM sees MACD Histogram just turned negative
EVCM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 28, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 35 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for EVCM moved out of overbought territory on October 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 21 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 72%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EVCM as a result. In 63 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
EVCM moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 10-day moving average for EVCM crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVCM advanced for three days, in 212 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
EVCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 134 of 191 cases where EVCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. EVCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.062) is normal, around the industry mean (-2.526). P/E Ratio (41.750) is within average values for comparable stocks, (15.160). Projected Growth (PEG Ratio) (0.350) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (2.417) is also within normal values, averaging (70.854).
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
HCAT's Indicator enters downward trend
The Aroon Indicator for HCAT entered a downward trend on October 28, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 293 similar instances where the Aroon Indicator formed such a pattern. In 265 of the 293 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HCAT as a result. In 80 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for HCAT turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 42 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
HCAT moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HCAT crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HCAT's RSI Oscillator exited the oversold zone, 30 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 50-day moving average for HCAT moved above the 200-day moving average on October 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
HCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.120) is normal, around the industry mean (4.793). P/E Ratio (-0.408) is within average values for comparable stocks, (13.685). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. HCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
HCAT | ||
|---|---|---|
OUTLOOK RATING 1..100 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 64 | |
P/E GROWTH RATING 1..100 | 15 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EVCM | HCAT | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 72% | 2 days ago 68% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 87% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| Advances ODDS (%) | 16 days ago 70% | N/A |
| Declines ODDS (%) | 4 days ago 81% | 4 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 75% | 2 days ago 85% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EVCM’s FA Score shows that 0 FA rating(s) are green while HCAT’s FA Score has 1 green FA rating(s).
- EVCM’s FA Score: 0 green, 5 red.
- HCAT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EVCM’s TA Score shows that 5 TA indicator(s) are bullish while HCAT’s TA Score has 4 bullish TA indicator(s).
- EVCM’s TA Score: 5 bullish, 5 bearish.
- HCAT’s TA Score: 4 bullish, 6 bearish.
Price Growth
EVCM (@Packaged Software) experienced а -8.74% price change this week, while HCAT (@Services to the Health Industry) price change was -16.20% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -2.46%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was -4.64%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.63%. For the same industry, the average monthly price growth was -2.00%, and the average quarterly price growth was +9.74%.
Reported Earning Dates
EVCM is expected to report earnings on Mar 18, 2027.
HCAT is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Packaged Software (-2.46% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-1.63% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
EVCM and
Correlation & Price change
A.I.dvisor indicates that over the last year, EVCM has been loosely correlated with LYFT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EVCM jumps, then LYFT could also see price increases.
| Ticker / NAME | Correlation To EVCM | 1D Price Change % | ||
|---|---|---|---|---|
| EVCM | 100% | -2.00% | ||
| LYFT - EVCM | 53% Loosely correlated | -4.80% | ||
| PLUS - EVCM | 52% Loosely correlated | -8.89% | ||
| ALIT - EVCM | 52% Loosely correlated | +0.55% | ||
| WEAV - EVCM | 50% Loosely correlated | N/A | ||
| FSLY - EVCM | 48% Loosely correlated | -26.88% | ||
More | ||||
HCAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.
| Ticker / NAME | Correlation To HCAT | 1D Price Change % | ||
|---|---|---|---|---|
| HCAT | 100% | -5.66% | ||
| KVYO - HCAT | 47% Loosely correlated | -2.57% | ||
| EVCM - HCAT | 46% Loosely correlated | -2.00% | ||
| RDVT - HCAT | 45% Loosely correlated | -9.85% | ||
| CPAY - HCAT | 43% Loosely correlated | +6.78% | ||
| COIN - HCAT | 43% Loosely correlated | -9.69% | ||
More | ||||